Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Agilent management ‘confident’ about growth outlook: analysts

Citi analysts had a “constructive” meeting with Agilent Technologies Inc (NYSE:A) management this week, given the various growth drivers for the company into next year.

This “should translate into earnings leverage," the analysts wrote in a note to clients on Thursday.

They said the company’s management sounded “confident” on Agilent’s growth outlook for fiscal 2026.

“Agilent is also positioned strongly on margins in its fiscal fourth quarter 2025 and fiscal 2026, where benefits should flow through off strong topline/volume growth, Ignite, and tariff impacts easing next year,” the analysts added.

Citi analysts have a ‘Buy’ rating on the stock with a target price of $165 per share.

Agilent Technologies shares were off 0.5% to $137.96 on Thursday.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK